Skip to main content

Advertisement

Log in

Optimizing Outcomes of Sacral Neuromodulation for the Treatment of Urinary Retention

  • Voiding Dysfunction Evaluation (C Gomez, Section Editor)
  • Published:
Current Bladder Dysfunction Reports Aims and scope Submit manuscript

Abstract

Sacral neuromodulation (SNM) is one of the few treatment options for patients suffering from non-obstructive urinary retention (NOUR) aside from intermittent or continuous bladder drainage. We describe the surgical techniques of device implantation in these patients and compare advantages and disadvantages of various approaches. We review the mechanism of action of SNM in the context of NOUR and summarize the evidence supporting using this treatment for these patients. We also describe SNM in the setting of Fowler syndrome and how this subset of patients can uniquely benefit.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

Papers of particular interest, published recently, are highlighted as: • Of importance •• Of major importance

  1. Blaivas JG, Groutz A. Bladder outlet obstruction nomogram for women with lower urinary tract symptomatology. Neurourol Urodyn. 2000;19:553–64.

    Article  CAS  PubMed  Google Scholar 

  2. Cormier L, Ferchaud J, Galas JM, Guillemin F, Mangin P. Diagnosis of female bladder outlet obstruction and relevance of the parameter area under the curve of detrusor pressure during voiding: preliminary results. J Urol. 2002;167:2083–7.

    Article  PubMed  Google Scholar 

  3. Tanagho EA, Schmidt RA. Bladder pacemaker: scientific basis and clinical future. Urology. 1982;20:614–9.

    Article  CAS  PubMed  Google Scholar 

  4. Tanagho EA, Schmidt RA, Orvis BR. Neural stimulation for control of voiding dysfunction: a preliminary report in 22 patients with serious neuropathic voiding disorders. J Urol. 1989;142:340–5.

    CAS  PubMed  Google Scholar 

  5. Siegel SW. Selecting patients for sacral nerve stimulation. The Urologic clinics of North America. 2005;32:19–26.

    Article  PubMed  Google Scholar 

  6. Thompson JH, Sutherland SE, Siegel SW. Sacral neuromodulation: therapy evolution. Indian journal of urology : IJU : journal of the Urological Society of India. 2010;26:379–84.

    Article  Google Scholar 

  7. Scheepens WA, Weil EH, van Koeveringe GA, et al. Buttock placement of the implantable pulse generator: a new implantation technique for sacral neuromodulation—a multicenter study. Eur Urol. 2001;40:434–8.

    Article  CAS  PubMed  Google Scholar 

  8. van Voskuilen AC, Oerlemans DJ, Weil EH, de Bie RA, van Kerrebroeck PE. Long term results of neuromodulation by sacral nerve stimulation for lower urinary tract symptoms: a retrospective single center study. Eur Urol. 2006;49:366–72.

    Article  PubMed  Google Scholar 

  9. Siegel S, Noblett K, Mangel J, et al. Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder. Neurourol Urodyn. 2015;34:224–30.

    Article  PubMed  Google Scholar 

  10. Borawski KM, Foster RT, Webster GD, Amundsen CL. Predicting implantation with a neuromodulator using two different test stimulation techniques: a prospective randomized study in urge incontinent women. Neurourol Urodyn. 2007;26:14–8.

    Article  PubMed  Google Scholar 

  11. Leong RK, De Wachter SG, Nieman FH, de Bie RA, van Kerrebroeck PE. PNE versus 1st stage tined lead procedure: a direct comparison to select the most sensitive test method to identify patients suitable for sacral neuromodulation therapy. Neurourol Urodyn. 2011;30:1249–52.

    PubMed  Google Scholar 

  12. Elneil S. Urinary retention in women and sacral neuromodulation. Int Urogynecol J. 2010;21 Suppl 2:S475–483.

    Article  PubMed  Google Scholar 

  13. Fowler CJ, Christmas TJ, Chapple CR, Parkhouse HF, Kirby RS, Jacobs HS. Abnormal electromyographic activity of the urethral sphincter, voiding dysfunction, and polycystic ovaries: a new syndrome? BMJ. 1988;297:1436–8.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Moore T. Bladder-neck obstruction in women. Proceedings of the Royal Society of Medicine. 1953;46:558–64.

    CAS  PubMed  PubMed Central  Google Scholar 

  15. Raz S, Smith RB. External sphincter spasticity syndrome in female patients. J Urol. 1976;115:443–6.

    CAS  PubMed  Google Scholar 

  16. Fowler CJ, Kirby RS, Harrison MJ. Decelerating burst and complex repetitive discharges in the striated muscle of the urethral sphincter, associated with urinary retention in women. J Neurol Neurosurg Psychiatry. 1985;48:1004–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. DasGupta R, Fowler CJ. The management of female voiding dysfunction: Fowler’s syndrome—a contemporary update. Curr Opin Urol. 2003;13:293–9.

    Article  PubMed  Google Scholar 

  18. Kavia RB, Datta SN, Dasgupta R, Elneil S, Fowler CJ. Urinary retention in women: its causes and management. BJU Int. 2006;97:281–7.

    Article  PubMed  Google Scholar 

  19. De Ridder D, Ost D, Bruyninckx F. The presence of Fowler’s syndrome predicts successful long-term outcome of sacral nerve stimulation in women with urinary retention. Eur Urol. 2007;51:229–33. discussion 233–224. Compared to idiopathic urinary retention, patients with a diagnosis of Fowler syndrome had greater and longer improvement in their voiding function as well as less revisions for technical failure.

    Article  PubMed  Google Scholar 

  20. Amend B, Matzel KE, Abrams P, de Groat WC, Sievert KD. How does neuromodulation work. Neurourol Urodyn. 2011;30:762–5.

    Article  PubMed  Google Scholar 

  21. Elkelini MS, Pravdivyi I, Hassouna MM. Mechanism of action of sacral nerve stimulation using a transdermal amplitude-modulated signal in a spinal cord injury rodent model. Canadian Urological Association journal = Journal de l’Association des urologues du Canada. 2012;6:227–30.

    Article  PubMed  PubMed Central  Google Scholar 

  22. Leng WW, Chancellor MB. How sacral nerve stimulation neuromodulation works. The Urologic clinics of North America. 2005;32:11–8.

    Article  PubMed  Google Scholar 

  23. Wang Y, Hassouna MM. Neuromodulation reduces c-fos gene expression in spinalized rats: a double-blind randomized study. J Urol. 2000;163:1966–70.

    Article  CAS  PubMed  Google Scholar 

  24. Zhou Y, Wang Y, Abdelhady M, Mourad MS, Hassouna MM. Change of vanilloid receptor 1 following neuromodulation in rats with spinal cord injury. J Surg Res. 2002;107:140–4.

    Article  CAS  PubMed  Google Scholar 

  25. Dasgupta R, Critchley HD, Dolan RJ, Fowler CJ. Changes in brain activity following sacral neuromodulation for urinary retention. J Urol. 2005;174:2268–72. This report provides evidence using neuro-imaging in the ability of SNM to restore brainstem auto regulation and attenuation of cortical activity.

    Article  PubMed  Google Scholar 

  26. Athwal BS, Berkley KJ, Hussain I, et al. Brain responses to changes in bladder volume and urge to void in healthy men. Brain : a journal of neurology. 2001;124:369–77.

    Article  CAS  Google Scholar 

  27. Matsuura S, Kakizaki H, Mitsui T, Shiga T, Tamaki N, Koyanagi T. Human brain region response to distention or cold stimulation of the bladder: a positron emission tomography study. J Urol. 2002;168:2035–9.

    Article  PubMed  Google Scholar 

  28. Taniguchi N, Miyata M, Yachiku S, Kaneko S, Yamaguchi S, Numata A. A study of micturition inducing sites in the periaqueductal gray of the mesencephalon. J Urol. 2002;168:1626–31.

    Article  PubMed  Google Scholar 

  29. Grunewald V, Hofner K, Thon WF, Kuczyk MA, Jonas U. Sacral electrical neuromodulation as an alternative treatment option for lower urinary tract dysfunction. Restor Neurol Neurosci. 1999;14:189–93.

    CAS  Google Scholar 

  30. Aboseif S, Tamaddon K, Chalfin S, Freedman S, Kaptein J. Sacral neuromodulation as an effective treatment for refractory pelvic floor dysfunction. Urology. 2002;60:52–6.

    Article  PubMed  Google Scholar 

  31. Elabbady AA, Hassouna MM, Elhilali MM. Neural stimulation for chronic voiding dysfunctions. J Urol. 1994;152:2076–80.

    CAS  PubMed  Google Scholar 

  32. Shaker HS, Hassouna M. Sacral root neuromodulation in idiopathic nonobstructive chronic urinary retention. J Urol. 1998;159:1476–8.

    Article  CAS  PubMed  Google Scholar 

  33. Jonas U, Fowler CJ, Chancellor MB, et al. Efficacy of sacral nerve stimulation for urinary retention: results 18 months after implantation. J Urol. 2001;165:15–9. This prospective randomized multi-center trial demonstrated that compared to standard medical therapy, NOUR patients who received SNM had clinically significant reductions in catheter volumes and more than two thirds of the patients eliminated catheterization all together.

    Article  CAS  PubMed  Google Scholar 

  34. Datta SN, Chaliha C, Singh A, et al. Sacral neurostimulation for urinary retention: 10-year experience from one UK centre. BJU Int. 2008;101:192–6.

    PubMed  Google Scholar 

  35. White WM, Dobmeyer-Dittrich C, Klein FA, Wallace LS. Sacral nerve stimulation for treatment of refractory urinary retention: long-term efficacy and durability. Urology. 2008;71:71–4. With follow-up of over 3 years 55% of patients with multifactorial NOUR were able to eliminate catheterization completely. In that time period, device explantation was performed in 14.2% of the patients due to infection, pain and need for MRI.

    Article  PubMed  Google Scholar 

  36. Gross C, Habli M, Lindsell C, South M. Sacral neuromodulation for nonobstructive urinary retention: a meta-analysis. Female pelvic medicine & reconstructive surgery. 2010;16:249–53. Using 13 observational studies and 1 randomized controlled study this meta-analysis demonstrated statistically significant improvement in mean catheterized volume and voided volume proving that sacral neuromodulation is an effective therapy for treatment of NOUR.

    Article  Google Scholar 

  37. Miyazato M, Yoshimura N, Chancellor MB. The other bladder syndrome: underactive bladder. Reviews in urology. 2013;15:11–22.

    PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Daniel Liberman.

Ethics declarations

Conflict of Interest

Dr. Liberman has no conflict of interest.

Dr. Ehlert declares that he is a paid consultant for Nuvectra.

Dr. Siegel declares that he has the folllowing conflicts of interest: Medtronic (paid consultant, sponsored research, proctor, speaker), Allergen (paid consultant, sponsored research), IPSEN (sponsored research) and NuVectra (paid consultant).

Human and Animal Rights and Informed Consent

This article does not contain studies with human or animal subjects performed by the author.

Additional information

This article is part of the Topical Collection on Voiding Dysfunction Evaluation

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Liberman, D., Ehlert, M.J. & Siegel, S.W. Optimizing Outcomes of Sacral Neuromodulation for the Treatment of Urinary Retention. Curr Bladder Dysfunct Rep 11, 272–276 (2016). https://doi.org/10.1007/s11884-016-0373-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11884-016-0373-4

Keywords

Navigation